as on September 16, 2025 at 1:29 am IST
Day's Low
Day's High
1.12%
Downside
1.39%
Upside
52 Week's Low
52 Week's High
28.70%
Downside
85.00%
Upside
Check Crinetics Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$3.2B
EPS (TTM)
-4.6655
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-16.31
Industry PE ratio
10.127857142857144
P/B Ratio
0PEG Ratio
0EBITDA
-419.6M
Revenue (TTM)
1.4M
Profit Margin
0.00%
Return On Equity TTM
0.00%
Track how Crinetics Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.
Crinetics Pharmaceuticals Inc in the last 5 years
Lowest (0.00x)
September 15, 2025
Today (-16.31x)
September 15, 2025
Industry (10.13x)
September 15, 2025
Highest (0.00x)
September 15, 2025
Today’s Price to Earnings Ratio: -16.31x
Compare market cap, revenue, PE, and other key metrics of Crinetics Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $3.2B | 118.48% | -16.31 | 0.00% | |
BUY | $61.1B | 256.98% | -505.15 | -12.96% | |
NA | $38.7B | NA | NA | -3.89% | |
BUY | $101.1B | 47.85% | 28.07 | 31.86% | |
BUY | $59.4B | -3.43% | 14.11 | 31.37% |
The Crinetics Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Crinetics Pharmaceuticals Inc investment value today
Current value as on today
₹67,811
Returns
Returns from Crinetics Pharmaceuticals Inc Stock
Dollar Returns*
₹4,985 (+4.99%)
Based on 20 analysts
90.00%
Buy
10.00%
Hold
0.00%
Sell
Based on 20 analysts, 90% of analysts recommend a 'BUY' rating for Crinetics Pharmaceuticals Inc. Average target price of $70
Get share price movements and forecasts by analysts on Crinetics Pharmaceuticals Inc.
What analysts predicted
51.71%UPSIDE
Target Price
$70
Current Price
$33.8
Analyzed by
20 Analysts
Target
$70.00
Crinetics Pharmaceuticals Inc target price $70, a slight upside of 51.71% compared to current price of $33.8. According to 20 analysts rating.
Search interest for Crinetics Pharmaceuticals Inc Stock has increased by 100% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:100% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 2 quarters, 361.0K → 1.03M (in $), with an average increase of 65.0% per quarter
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 64.4%
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 112.4%
Profit Down
Netprofit is down for the last 12 quarters, -40.39M → -115.63M (in $), with an average decrease of 10.2% per quarter
Price Dip
In the last 7 days, CRNX stock has moved down by -3.2%
Organisation | Crinetics Pharmaceuticals Inc |
Headquarters | 6055 Lusk Boulevard, San Diego, CA, United States, 92121 |
Industry | Health Technology |
CEO | Dr. R. Scott Struthers Ph.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Dr. Alan S. Krasner M.D. | Chief Endocrinologist |
Mr. Kevin Capps | Head of Intellectual Property |
Dr. Stephen F. Betz Ph.D. | Co-Founder & Chief Scientific Officer |
Dr. Dana Pizzuti M.D. | Chief Medical & Development Officer |
Mr. Tobin C. Schilke | Chief Financial Officer |
Ms. Garlan Adams J.D. | Chief Legal Officer & Corporate Secretary |
Dr. R. Scott Struthers Ph.D. | Founder, President, CEO & Director |
Mr. Jeff E. Knight M.P.H. | Chief Operating Officer |
Ms. Gayathri Diwakar | Senior Director of Investor Relations |
Ms. Adriana Cabre M.B.A. | Chief Human Resources Officer |
Crinetics Pharmaceuticals Inc share price today is $33.8 as on at the close of the market. Crinetics Pharmaceuticals Inc share today touched a day high of $34.27 and a low of $33.42.
Crinetics Pharmaceuticals Inc share touched a 52 week high of $62.53 on and a 52 week low of $24.1 on . Crinetics Pharmaceuticals Inc stock price today i.e. is closed at $33.8,which is 45.95% down from its 52 week high and 40.25% up from its 52 week low.
Crinetics Pharmaceuticals Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Crinetics Pharmaceuticals Inc (CRNX) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Crinetics Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Crinetics Pharmaceuticals Inc share’s latest price of $33.8 as on September 16, 2025 at 1:29 am IST, you will get 0.2959 shares of Crinetics Pharmaceuticals Inc. Learn more about
fractional shares .
Crinetics Pharmaceuticals Inc stock has given 118.48% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?